Pathology of Malignant Mesothelioma

Alberto M. Marchevsky; Françoise Galateau-Sallé; Lucian Chirieac; Aliya N. Husain

doi:10.1017/9781316402009.012

11 - Pathology of Malignant Mesothelioma

Published online by Cambridge University Press: 16 March 2018

Alberto M. Marchevsky ,

Françoise Galateau-Sallé ,

Lucian Chirieac and

Aliya N. Husain

Edited by

Alberto M. Marchevsky ,

Aliya N. Husain and

Françoise Galateau-Sallé

Show author details

Alberto M. Marchevsky: Affiliation:
Cedars Sinai Medical Center, Los Angeles
Aliya N. Husain: Affiliation:
University of Chicago
Françoise Galateau-Sallé: Affiliation:
MESOPATH National Reference Center & Cancer Center Leon Berard

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Chapter
Information: Practical Pathology of Serous Membranes , pp. 115 - 175

DOI: https://doi.org/10.1017/9781316402009.012 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Churg, A, Roggli, V, Chirieac, LR, Galateau-Sallé, F, Burczuk, A, Dacic, S, et al. Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.Google Scholar

Galateau-Sallé, F, Churg, A, Roggli, V, Chirieac, LR, Burczuk, A, Cagle, P, et al. Mesothelial tumors. Diffuse malignant mesothelioma. Epithelioid mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.Google Scholar

Husain, AN, Colby, T, Ordonez, N, Krausz, T, Attanoos, R, Beasley, MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137;647–67.CrossRef Google Scholar PubMed

Roggli, V, Borczuk, A, Chirieac, LR, Churg, A, Dacic, S, Galateau-Sallé, F, et al. Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.Google Scholar

de Klerk, DP, Nime, F. Adenomatoid tumors (mesothelioma) of testicular and paratesticular tissue. Urology. 1975;6:635–41.CrossRef Google Scholar PubMed

Amin, W, Parwani, AV. Adenomatoid tumor of testis. Clin Med Pathol. 2009;2;17–22.CrossRef Google Scholar PubMed

Gkentzis, A, Sawalem, K, Husain, J. An unusual case of paratesticular mesothelioma on the site of previously excised epididymal adenomatoid tumour. Int J Surg Case Rep. 2013;4:460–62.CrossRef Google Scholar PubMed

Hatano, Y, Hirose, Y, Matsunaga, K, Kito, Y, Yasuda, I, Moriwaki, H, et al. Combined adenomatoid tumor and well differentiated papillary mesothelioma of the omentum. Pathol Int. 2011;61:681–85.CrossRef Google Scholar PubMed

Makkar, M, Dayal, P, Gupta, C, Mahajan, N. Adenomatoid tumor of testis: a rare cytological diagnosis. J Cytol. 2013;30:65–67.CrossRef Google Scholar PubMed

Minato, H, Nojima, T, Kurose, N, Kinoshita, E. Adenomatoid tumor of the pleura. Pathol Int. 2009;59:567–71.CrossRef Google Scholar PubMed

Bisset, DL, Morris, JA, Fox, H. Giant cystic adenomatoid tumour (mesothelioma) of the uterus. Histopathology. 1988;12:555–58.CrossRef Google Scholar PubMed

Chan, JK, Fong, MH. Composite multicystic mesothelioma and adenomatoid tumour of the uterus: different morphological manifestations of the same process? Histopathology. 1996;29:375–77.Google Scholar

Katsube, Y, Mukai, K, Silverberg, SG. Cystic mesothelioma of the peritoneum: a report of five cases and review of the literature. Cancer. 1982;50:1615–22.Google Scholar

Kawai, T, Kawashima, K, Serizawa, H, Miura, H, Kyeongil, K. Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings. Diagn Cytopathol. 2014;42:436–40.CrossRef Google Scholar PubMed

Kurisu, Y, Tsuji, M, Shibayama, Y, Yamada, T, Ohmichi, M. Multicystic mesothelioma caused by endometriosis: 2 case reports and review of the literature. Int J Gynecol Pathol. 2011;30:163–66.Google Scholar

Sawada, K, Inoue, K, Ishihara, T, Kurabayashi, A, Moriki, T, Shuin, T. Multicystic malignant mesothelioma of the tunica vaginalis with an unusually indolent clinical course. Hinyokika Kiyo. 2004;50:511–13.Google Scholar

Sheng, B, Zhang, YP, Wei, HH, Ma, M, Nan, X. Primary adenomatoid tumor of the testis: report of a case and review of literature. Int J Clin Exp Pathol. 2015;8:5914–18.Google Scholar PubMed

Terry, NE, Fowler, CL. Benign cystic mesothelioma in a child. J Pediatr Surg. 2009;44:e9–11.CrossRef Google Scholar PubMed

Weiss, SW, Tavassoli, FA. Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol. 1988;12:737–46.CrossRef Google Scholar PubMed

Chen, X, Sheng, W, Wang, J. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology. 2013;62:805–13.CrossRef Google Scholar PubMed

Hanrahan, JB. A combined papillary mesothelioma and adenomatoid tumor of the omentum; report of a case. Cancer. 1963;16:1497–500.Google Scholar

Zamecnik, M, Gomolcak, P. Composite multicystic mesothelioma and adenomatoid tumor of the ovary: additional observation suggesting common histogenesis of both lesions. Cesk Patol. 2000;36:160–62.Google Scholar PubMed

Abratt, RP, White, NW, Vorobiof, DA. Epidemiology of mesothelioma – a South African perspective. Lung Cancer. 2005;49(Suppl 1):S13–15.CrossRef Google Scholar PubMed

Andersson, M, Olsen, JH. Trend and distribution of mesothelioma in Denmark. Br J Cancer. 1985;51:699–705.CrossRef Google Scholar PubMed

Armstrong, BK, Musk, AW, Baker, JE, Hunt, JM, Newall, CC, Henzell, HR, et al. Epidemiology of malignant mesothelioma in Western Australia. Med J Aust. 1984;141:86–88.CrossRef Google Scholar PubMed

Ferguson, DA, Berry, G, Jelihovsky, T, Andreas, SB, Rogers, AJ, Fung, SC, et al. The Australian Mesothelioma Surveillance Program 1979–1985. Med J Aust. 1987;147:166–72.CrossRef Google Scholar PubMed

Goldberg, M, Imbernon, E, Rolland, P, Gilg, Soit Ilg A, Saves, M, de Quillacq, A, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006;63:390–95.CrossRef Google Scholar PubMed

Hinds, MW. Mesothelioma in the United States. Incidence in the 1970s. J Occup Med. 1978;20:469–71.CrossRef Google Scholar

Leigh, J, Driscoll, T. Malignant mesothelioma in Australia, 1945–2002. Int J Occup Environ Health. 2003;9:206–17.CrossRef Google Scholar PubMed

McDonald, AD, McDonald, JC. Malignant mesothelioma in North America. Cancer. 1980;46:1650–56.3.0.CO;2-Y>CrossRef Google Scholar PubMed

Peto, J, Decarli, A, La Vecchia, C, Levi, F, Negri, E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666–72.CrossRef Google Scholar PubMed

Price, B, Ware, A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39:576–88.CrossRef Google Scholar PubMed

Price, B, Ware, A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159:107–12.CrossRef Google Scholar PubMed

Robinson, BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1:491–96.Google Scholar PubMed

Cao, S, Jin, S, Cao, J, Shen, J, Hu, J, Che, D, et al. Advances in malignant peritoneal mesothelioma. Int J Colorectal Dis. 2015;30:1–10.CrossRef Google Scholar PubMed

Ramachandran, R, Radhan, P, Santosham, R, Rajendiran, S. A rare case of primary malignant pericardial mesothelioma. J Clin Imaging Sci. 2014;4:47.CrossRef Google Scholar PubMed

Tateishi, K, Ikeda, M, Yokoyama, T, Urushihata, K, Yamamoto, H, Hanaoka, M, et al. Primary malignant sarcomatoid mesothelioma in the pericardium. Intern Med. 2013;52:249–53.CrossRef Google Scholar PubMed

Kayatta, MO, Dineen, SP, Sica, G, Puskas, JD, Pickens, A. Primary pericardial mesothelioma in a 19-year-old presenting as pericarditis. Ann Thorac Surg. 2013;96:680–81.CrossRef Google Scholar

Jiang, D, Kong, M, Li, J, Qian, J. Primary sarcomatoid malignant pericardial mesothelioma. Intern Med. 2013;52:157–58.CrossRef Google Scholar PubMed

Godar, M, Liu, J, Zhang, P, Xia, Y, Yuan, Q. Primary pericardial mesothelioma: a rare entity. Case Rep Oncol Med. 2013;2013:283601.Google Scholar

Akin, Y, Bassorgun, I, Basara, I, Yucel, S. Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors. Singapore Med J. 2015;56:e53–55.CrossRef Google Scholar PubMed

Yang, LH, Yu, JH, Xu, HT, Lin, XY, Liu, Y, Miao, Y, et al. Mesothelioma of the tunica vaginalis testis with prominent adenomatoid features: a case report. Int J Clin Exp Pathol. 2014;7:7082–87.Google Scholar PubMed

Rajan, V, Nandhakumar, R, Shanmugasundaram, S, Ravi, R, Natarajan, S, Mohan, G, et al. Paratesticular malignant mesothelioma – a rare case presentation. Indian J Surg. 2013;75:174–76.CrossRef Google Scholar PubMed

Yen, CH, Lee, CT, Su, CJ, Lo, HC. Malignant mesothelioma of the tunica vaginalis testis: a malignancy associated with recurrent epididymitis? World J Surg Oncol. 2012;10:238.CrossRef Google Scholar PubMed

Mrinakova, B, Ondrus, D, Kajo, K, Kunderlik, M, Tkacova, M, Ondrusova, M. Paratesticular mesothelioma in young age. Case report. Klin Onkol. 2012;25:290–93.Google Scholar PubMed

Mensi, C, Pellegatta, M, Sieno, C, Consonni, D, Riboldi, L, Bertazzi, PA. Mesothelioma of tunica vaginalis testis and asbestos exposure. BJU Int. 2012;110:533–37.CrossRef Google Scholar PubMed

Corfiati, M, Scarselli, A, Binazzi, A, Di Marzio, D, Verardo, M, Mirabelli, D, et al. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer. 2015;15:286.CrossRef Google Scholar PubMed

Beckett, P, Edwards, J, Fennell, D, Hubbard, R, Woolhouse, I, Peake, MD. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer. 2015;88:344–48.Google Scholar

Kataoka, Y, Yamamoto, Y, Otsuki, T, Shinomiya, M, Terada, T, Fukuma, S, et al. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index. Jpn J Clin Oncol. 2015;45(6):562–68.CrossRef Google Scholar PubMed

Meyerhoff, RR, Yang, CF, Speicher, PJ, Gulack, BC, Hartwig, MG, D'Amico, TA, et al. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surg Res. 2015;196:23–32.CrossRef Google Scholar PubMed

Najmi, K, Khosravi, A, Seifi, S, Emami, H, Chaibakhsh, S, Radmand, G, et al. Clinicopathologic and survival characteristics of malignant pleural mesothelioma registered in hospital cancer registry. Tanaffos. 2014;13:6–12.Google Scholar PubMed

Rolland, P, Gramond, C, Lacourt, A, Astoul, P, Chamming's, S, Ducamp, S, et al. Occupations and industries in France at high risk for pleural mesothelioma: a population-based case-control study (1998–2002). Am J Ind Med. 2010;53:1207–19.CrossRef Google Scholar PubMed

McDonald, JC. Epidemiology of malignant mesothelioma – an outline. Ann Occup Hyg. 2010;54:851–57.Google Scholar

Teta, MJ, Mink, PJ, Lau, E, Sceurman, BK, Foster, ED. US mesothelioma patterns 1973–2002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008;17:525–34.CrossRef Google Scholar PubMed

Gibbs, GW, Berry, G. Mesothelioma and asbestos. Regul Toxicol Pharmacol. 2008;52:S223–31.CrossRef Google Scholar PubMed

Robinson, BW, Lake, RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–603.CrossRef Google Scholar PubMed

McElvenny, DM, Darnton, AJ, Price, MJ, Hodgson, JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond). 2005;55:79–87.CrossRef Google Scholar PubMed

Hodgson, JT, McElvenny, DM, Darnton, AJ, Price, MJ, Peto, J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587–93.Google Scholar

Musk, AW, de Klerk, NH. Epidemiology of malignant mesothelioma in Australia. Lung Cancer. 2004;45(Suppl 1):S21–23.CrossRef Google Scholar PubMed

Faig, J, Howard, S, Levine, EA, Casselman, G, Hesdorffer, M, Ohar, JA. Changing pattern in malignant mesothelioma survival. Transl Oncol. 2015;8:35–39.CrossRef Google Scholar PubMed

Neumann, V, Loseke, S, Nowak, D, Herth, FJ, Tannapfel, A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int. 2013;110:319–26.Google Scholar PubMed

Frost, G. The latency period of mesothelioma among a cohort of British asbestos workers (1978–2005). Br J Cancer. 2013;109:1965–73.CrossRef Google Scholar PubMed

Bianchi, C, Giarelli, L, Grandi, G, Brollo, A, Ramani, L, Zuch, C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev. 1997;6:162–66.Google Scholar PubMed

Craighead, JE. Epidemiology of mesothelioma and historical background. Recent Results Cancer Res. 2011;189:13–25.CrossRef Google Scholar PubMed

Berman, DW, Crump, KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1):1–47.CrossRef Google Scholar PubMed

McDonald, AD, Case, BW, Churg, A, Dufresne, A, Gibbs, GW, Sebastien, P, et al. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg. 1997;41:707–19.CrossRef Google Scholar PubMed

McDonald, JC. Tremolite, other amphiboles, and mesothelioma. Am J Ind Med. 1988;14:247–49.CrossRef Google Scholar PubMed

Churg, A. Chrysotile, tremolite, and malignant mesothelioma in man. Chest. 1988;93:621–28.CrossRef Google Scholar PubMed

Churg, A. Malignant mesothelioma in British Columbia in 1982. Cancer. 1985;55:672–74.3.0.CO;2-Z>CrossRef Google Scholar PubMed

Garabrant, DH, Alexander, DD, Miller, PE, Fryzek, JP, Boffetta, P, Teta, MJ, et al. Mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. Ann Occup Hyg. 2016;60:8–26.CrossRef Google Scholar PubMed

McDonald, JC, McDonald, AD. The epidemiology of mesothelioma in historical context. Eur Respir J. 1996;9:1932–42.CrossRef Google Scholar PubMed

Yarborough, CM. The risk of mesothelioma from exposure to chrysotile asbestos. Curr Opin Pulm Med. 2007;13:334–38.CrossRef Google Scholar PubMed

Yarborough, CM. Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Crit Rev Toxicol. 2006;36:165–87.CrossRef Google Scholar PubMed

Lee, D. Genetic basis of mesothelioma – more than asbestos exposure. J Thorac Oncol. 2016;11:e27–28.CrossRef Google Scholar PubMed

Ohar, JA, Cheung, M, Talarchek, J, Howard, SE, Howard, TD, Hesdorffer, M, et al. Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer. Cancer Res. 2016;76:206–15.CrossRef Google Scholar PubMed

Abakay, A, Tanrikulu, AC, Ayhan, M, Imamoglu, MS, Taylan, M, Kaplan, MA, et al. High-risk mesothelioma relation to meteorological and geological condition and distance from naturally occurring asbestos. Environ Health Prev Med. 2016;21:82–90.Google Scholar

Chirieac, LR, Barletta, JA, Yeap, BY, Richards, WG, Tilleman, T, Bueno, R, et al. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol. 2013;31:4544–49.CrossRef Google Scholar PubMed

Baumann, F, Buck, BJ, Metcalf, RV, McLaurin, BT, Merkler, DJ, Carbone, M. The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from southern Nevada. J Thorac Oncol. 2015;10:731–37.Google Scholar

Demirer, E, Ghattas, CF, Radwan, MO, Elamin, EM. Clinical and prognostic features of erionite-induced malignant mesothelioma. Yonsei Med J. 2015;56:311–23.CrossRef Google Scholar PubMed

Kanbay, A, Ozer, Simsek Z, Tutar, N, Yilmaz, I, Buyukoglan, H, Canoz, O, et al. Non-asbestos-related malignant pleural mesothelioma. Intern Med. 2014;53:1977–79.CrossRef Google Scholar PubMed

Carbone, M, Baris, YI, Bertino, P, Brass, B, Comertpay, S, Dogan, AU, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A 2011;108:13618–23.CrossRef Google Scholar PubMed

Metintas, M, Hillerdal, G, Metintas, S, Dumortier, P. Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors. Arch Environ Occup Health. 2010;65:86–93.CrossRef Google Scholar PubMed

Dodson, RF, Mark, EJ, Poye, LW. Biodurability/retention of Libby amphiboles in a case of mesothelioma. Ultrastruct Pathol. 2014;38:45–51.CrossRef Google Scholar

Jasani, B, Gibbs, A. Mesothelioma not associated with asbestos exposure. Arch Pathol Lab Med. 2012;136:262–67.CrossRef Google Scholar

Dikensoy, O. Mesothelioma due to environmental exposure to erionite in Turkey. Curr Opin Pulm Med. 2008;14:322–25.CrossRef Google Scholar PubMed

Carbone, M, Emri, S, Dogan, AU, Steele, I, Tuncer, M, Pass, HI, et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7:147–54.Google Scholar

Emri, S, Demir, AU. Malignant pleural mesothelioma in Turkey, 2000–2002. Lung Cancer. 2004;45(Suppl 1):S17–20.CrossRef Google Scholar PubMed

Farioli, A, Violante, FS, Mattioli, S, Curti, S, Kriebel, D. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control. 2013;24:1535–45.CrossRef Google Scholar PubMed

De Bruin, ML, Burgers, JA, Baas, P, van 't Veer, MB, Noordijk, EM, Louwman, MW, et al. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood. 2009;113:3679–81.CrossRef Google Scholar PubMed

Witherby, SM, Butnor, KJ, Grunberg, SM. Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer. 2007;57:410–13.CrossRef Google Scholar PubMed

Velissaris, TJ, Tang, AT, Millward-Sadler, GH, Morgan, JM, Tsang, GM. Pericardial mesothelioma following mantle field radiotherapy. J Cardiovasc Surg (Torino). 2001;42:425–27.Google Scholar PubMed

Weissmann, LB, Corson, JM, Neugut, AI, Antman, KH. Malignant mesothelioma following treatment for Hodgkin's disease. J Clin Oncol. 1996;14:2098–100.CrossRef Google Scholar PubMed

Cavazza, A, Travis, LB, Travis, WD, Wolfe, JT, Foo, ML, Gillespie, DJ, et al. Post-irradiation malignant mesothelioma. Cancer. 1996;77:1379–85.3.0.CO;2-Y>CrossRef Google Scholar PubMed

Comar, M, Zanotta, N, Pesel, G, Visconti, P, Maestri, I, Rinaldi, R, et al. Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy. Tumori. 2012;98:210–14.CrossRef Google Scholar PubMed

Price, MJ, Darnton, AJ, McElvenny, DM, Hodgson, JT. Simian virus 40 and mesothelioma in Great Britain. Occup Med (Lond). 2007;57:564–68.CrossRef Google Scholar PubMed

De Rienzo, A, Tor, M, Sterman, DH, Aksoy, F, Albelda, SM, Testa, JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem. 2002;84:455–59.Google Scholar

Carbone, M, Kratzke, RA, Testa, JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29:2–17.Google Scholar

Carbone, M, Fisher, S, Powers, A, Pass, HI, Rizzo, P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol. 1999;180:167–72.3.0.CO;2-Q>CrossRef Google Scholar PubMed

Wolff-Bar, M, Dujovny, T, Vlodavsky, E, Postovsky, S, Morgenstern, SM, Braslavsky, D, et al. An 8-year-old child with malignant deciduoid mesothelioma of the abdomen: report of a case and review of the literature. Pediatr Dev Pathol. 2015;18(4):327–30.Google Scholar

Taylor, S, Carpentieri, D, Williams, J, Acosta, J, Southard, R. Malignant peritoneal mesothelioma in an adolescent male with BAP1 deletion. J Pediatr Hematol Oncol. 2015;37(5):e323–27.CrossRef Google Scholar

Kobayashi, S, Waragai, T, Sano, H, Mochizuki, K, Akaihata, M, Ohara, Y, et al. Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments. Anticancer Drugs. 2014;25:1102–05.CrossRef Google Scholar

Sugalski, A, Davis, M, Prasannan, L, Saldivar, V, Hung, JY, Tomlinson, GE. Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child. Pediatr Blood Cancer. 2013;60:146–48.CrossRef Google Scholar

Rosas-Salazar, C, Gunawardena, SW, Spahr, JE. Malignant pleural mesothelioma in a child with ataxia–telangiectasia. Pediatr Pulmonol. 2013;48:94–97.CrossRef Google Scholar

Khan, MA, Puri, P, Devaney, D. Mesothelioma of tunica vaginalis testis in a child. J Urol. 1997;158:198–99.CrossRef Google Scholar PubMed

Fraire, AE, Cooper, S, Greenberg, SD, Buffler, P, Langston, C. Mesothelioma of childhood. Cancer. 1988;62:838–47.3.0.CO;2-9>CrossRef Google Scholar PubMed

Armstrong, GR, Raafat, F, Ingram, L, Mann, JR. Malignant peritoneal mesothelioma in childhood. Arch Pathol Lab Med. 1988;112:1159–62.Google Scholar PubMed

Berry, PJ, Favara, BE, Odom, LF. Malignant peritoneal mesothelioma in a child. Pediatr Pathol. 1986;5:397–409.CrossRef Google Scholar PubMed

Kovalivker, M, Motovic, A. Malignant peritoneal mesothelioma in children: description of two cases and review of the literature. J Pediatr Surg. 1985;20:274–75.CrossRef Google Scholar PubMed

Wassermann, M, Wassermann, D, Steinitz, R, Katz, L, Lemesch, C. Mesothelioma in children. IARC Sci Publ. 1980;30:253–57.Google Scholar

Kauffman, SL, Stout, AP. Mesothelioma in children. Cancer. 1964;17:539–44.3.0.CO;2-A>CrossRef Google Scholar PubMed

Ascoli, V, Romeo, E, Carnovale, Scalzo C, Cozzi, I, Ancona, L, Cavariani, F, et al. Familial malignant mesothelioma: a population-based study in central Italy (1980–2012). Cancer Epidemiol. 2014;38:273–78.CrossRef Google Scholar PubMed

Kalogeraki, AM, Tamiolakis, DJ, Lagoudaki, ED, Papadakis, MN, Papadakis, GZ, Agelaki, SI, et al. Familial mesothelioma in first degree relatives. Diagn Cytopathol. 2013;41:654–57.CrossRef Google Scholar PubMed

Serio, G, Scattone, A, Gentile, M, Nazzaro, P, Pennella, A, Buonadonna, AL, et al. Familial pleural mesothelioma with environmental asbestos exposure: losses of DNA sequences by comparative genomic hybridization (CGH). Histopathology. 2004;45:643–45.CrossRef Google Scholar PubMed

Musti, M, Cavone, D, Aalto, Y, Scattone, A, Serio, G, Knuutila, S. A cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly. Cancer Genet Cytogenet. 2002;138:73–76.CrossRef Google Scholar PubMed

Saracci, R, Simonato, L. Familial malignant mesothelioma. Lancet. 2001;358:1813–14.CrossRef Google Scholar PubMed

Ascoli, V, Scalzo, CC, Bruno, C, Facciolo, F, Lopergolo, M, Granone, P, et al. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett. 1998;130:203–07.CrossRef Google Scholar PubMed

Risberg, B, Nickels, J, Wagermark, J. Familial clustering of malignant mesothelioma. Cancer. 1980;45:2422–27.3.0.CO;2-Z>CrossRef Google Scholar PubMed

Baumann, F, Flores, E, Napolitano, A, Kanodia, S, Taioli, E, Pass, H, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36:76–81.Google Scholar

Betti, M, Casalone, E, Ferrante, D, Romanelli, A, Grosso, F, Guarrera, S, et al. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes Chromosomes Cancer. 2015;54:51–62.CrossRef Google Scholar

Xu, J, Kadariya, Y, Cheung, M, Pei, J, Talarchek, J, Sementino, E, et al. Germline mutation of BAP1 accelerates development of asbestos-induced malignant mesothelioma. Cancer Res. 2014;74:4388–97.Google Scholar PubMed

Ribeiro, C, Campelos, S, Moura, CS, Machado, JC, Justino, A, Parente, B. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol. 2013;24:2147–50.Google Scholar

Carbone, M, Ferris, LK, Baumann, F, Napolitano, A, Lum, CA, Flores, EG, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10:179.Google Scholar

Testa, JR, Cheung, M, Pei, J, Below, JE, Tan, Y, Sementino, E, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43:1022–25.CrossRef Google Scholar PubMed

Rusch, A, Ziltener, G, Nackaerts, K, Weder, W, Stahel, RA, Felley-Bosco, E. Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer. 2015;87:77–79.CrossRef Google Scholar PubMed

Cheung, M, Talarchek, J, Schindeler, K, Saraiva, E, Penney, LS, Ludman, M, et al. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet. 2013;206:206–10.CrossRef Google Scholar PubMed

Marchevsky, AM, Harber, P, Crawford, L, Wick, MR. Mesothelioma in patients with nonoccupational asbestos exposure. An evidence-based approach to causation assessment. Ann Diagn Pathol. 2006;10:241–50.CrossRef Google Scholar PubMed

Robinson, BW, Musk, AW, Lake, RA. Malignant mesothelioma. Lancet. 2005;366:397–408.CrossRef Google Scholar PubMed

Choi, BY, Yoon, MJ, Shin, K, Lee, YJ, Song, YW. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus. 2015;24:321–26.CrossRef Google Scholar PubMed

Dogan, M, Utkan, G, Hocazade, C, Uncu, D, Toptas, S, Ozdemir, N, et al. The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. Med Oncol. 2014;31:232.CrossRef Google Scholar PubMed

Mott, FE. Mesothelioma: a review. Ochsner J. 2012;12:70–79.Google Scholar PubMed

Haber, SE, Haber, JM. Malignant mesothelioma: a clinical study of 238 cases. Ind Health. 2011;49:166–72.CrossRef Google Scholar PubMed

Gill, RR. Imaging of mesothelioma. Recent Results Cancer Res. 2011;189:27–43.CrossRef Google Scholar PubMed

Marrannes, J, Delvaux, S, Verheezen, J. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis. JBR-BTR. 2009;92:248–50.Google Scholar PubMed

Smith, TR. Malignant peritoneal mesothelioma: marked variability of CT findings. Abdom Imaging. 1994;19:27–29.CrossRef Google Scholar PubMed

Bianchi, C, Brollo, A, Ramani, L, Zuch, C. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study. Am J Ind Med. 1997;32:445–49.3.0.CO;2-R>CrossRef Google Scholar PubMed

Hillerdal, G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest. 1994;105:144–50.CrossRef Google Scholar PubMed

Borasio, P, Berruti, A, Bille, A, Lausi, P, Levra, MG, Giardino, R, et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg. 2008;33:307–13.CrossRef Google Scholar

Nickell, LT., Lichtenberger, JP, 3rd, Khorashadi, L, Abbott, GF, Carter, BW. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics. 2014;34:1692–706.CrossRef Google Scholar PubMed

Truong, MT, Viswanathan, C, Godoy, MB, Carter, BW, Marom, EM. Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations. Semin Roentgenol. 2013;48:323–34.CrossRef Google Scholar PubMed

Larsen, BT, Klein, JR, Hornychova, H, Nuti, R, Thirumala, S, Leslie, KO, et al. Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma. Am J Surg Pathol. 2013;37:1555–64.CrossRef Google Scholar PubMed

Amosite asbestos and mesothelioma. Lancet 1981;2:1397–98.Google Scholar

Boffetta, P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985–90.CrossRef Google Scholar PubMed

Suster, S, Moran, CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol. 2006;13:316–29.CrossRef Google Scholar PubMed

Hjerpe, A, Ascoli, V, Bedrossian, CW, Boon, ME, Creaney, J, Davidson, B, et al. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Acta Cytol. 2015;59:2–16.CrossRef Google Scholar PubMed

Kawai, T, Hiroshima, K, Kamei, T. Pulmonary Pathology: SY22–2 diagnosis of mesothelioma by cytology using Japanese criteria. Pathology. 2014;46(Suppl 2):S39.CrossRef Google Scholar

Segal, A, Sterrett, GF, Frost, FA, Shilkin, KB, Olsen, NJ, Musk, AW, et al. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Pathology. 2013;45:44–48.CrossRef Google Scholar PubMed

Paintal, A, Raparia, K, Zakowski, MF, Nayar, R. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey. Cancer Cytopathol. 2013;121:703–07.CrossRef Google Scholar PubMed

Arrossi, AV, Lin, E, Rice, D, Moran, CA. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Pathol. 2008;130:754–64.CrossRef Google Scholar PubMed

Burkholder, D, Hadi, D, Kunnavakkam, R, Kindler, H, Todd, K, Celauro, AD, et al. Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma. Ann Thorac Surg. 2015;99:1775–80.CrossRef Google Scholar PubMed

Cao, C, Tian, D, Park, J, Allan, J, Pataky, KA, Yan, TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83:240–45.CrossRef Google Scholar PubMed

Cardillo, G, Treasure, T. Extrapleural pneumonectomy is not shown to be clinically effective in the treatment of malignant pleural mesothelioma. Ann Surg. 2017;265(4):e53.Google Scholar

Chirieac, LR, Pinkus, GS, Pinkus, JL, Godleski, J, Sugarbaker, DJ, Corson, JM. The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura. Am J Cancer Res. 2011;1:14–24.Google Scholar PubMed

de Perrot, M, McRae, K, Anraku, M, Karkouti, K, Waddell, TK, Pierre, AF, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85:1206–10.CrossRef Google Scholar PubMed

Gupta, V, Krug, LM, Laser, B, Hudka, K, Flores, R, Rusch, VW, et al. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy. J Thorac Oncol. 2009;4:746–50.CrossRef Google Scholar PubMed

Sugarbaker, DJ, Wolf, AS, Chirieac, LR, Godleski, JJ, Tilleman, TR, Jaklitsch, MT, et al. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2011;40:298–303.Google Scholar PubMed

Taioli, E, Wolf, AS, Flores, RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99:472–80.CrossRef Google Scholar PubMed

Ito, T, Hamasaki, M, Matsumoto, S, Hiroshima, K, Tsujimura, T, Kawai, T, et al. p16/CDKN2A FISH in differentiation of diffuse malignant peritoneal mesothelioma from mesothelial hyperplasia and epithelial ovarian cancer. Am J Clin Pathol. 2015;143:830–38.CrossRef Google Scholar PubMed

Hasegawa, M, Sakai, F, Sato, A, Tsubomizu, S, Arimura, K, Katsura, H, et al. FISH analysis of intrapulmonary malignant mesothelioma without a clinically detectable primary pleural lesion: an autopsy case. Jpn J Clin Oncol. 2014;44:1239–42.CrossRef Google Scholar PubMed

Hwang, H, Tse, C, Rodriguez, S, Gown, A, Churg, A. p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma. Am J Surg Pathol. 2014;38:681–88.CrossRef Google Scholar PubMed

Wu, D, Hiroshima, K, Matsumoto, S, Nabeshima, K, Yusa, T, Ozaki, D, et al. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis. Am J Clin Pathol. 2013;139:39–46.Google Scholar

Matsumoto, S, Nabeshima, K, Kamei, T, Hiroshima, K, Kawahara, K, Hata, S, et al. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Cancer Cytopathol. 2013;121:415–22.Google Scholar

Al-Salam, S, Hammad, FT, Salman, MA, AlAshari, M. Expression of Wilms tumor-1 protein and CD 138 in malignant mesothelioma of the tunica vaginalis. Pathol Res Pract. 2009;205:797–800.CrossRef Google Scholar PubMed

Illei, PB, Ladanyi, M, Rusch, VW, Zakowski, MF. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 2003;99:51–56.CrossRef Google Scholar PubMed

Cheng, JQ, Jhanwar, SC, Klein, WM, Bell, DW, Lee, WC, Altomare, DA, et al. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 1994;54:5547–51.Google Scholar PubMed

Hiroshima, K, Wu, D, Hasegawa, M, Koh, E, Sekine, Y, Ozaki, D, et al. Cytologic differential diagnosis of malignant mesothelioma and reactive mesothelial cells with FISH analysis of p16. Diagn Cytopathol. 2016;44(7):591–98.CrossRef Google Scholar PubMed

Cigognetti, M, Lonardi, S, Fisogni, S, Balzarini, P, Pellegrini, V, Tironi, A, et al. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol. 2015;28:1043–57.CrossRef Google Scholar PubMed

Walts, AE, Hiroshima, K, McGregor, SM, Wu, D, Husain, AN, Marchevsky, AM. BAP1 immunostain and CDKN2A (p16) FISH analysis: clinical applicability for the diagnosis of malignant mesothelioma in effusions. Diagn Cytopathol. 2016;44(7):599–606.CrossRef Google Scholar PubMed

Roggli, V, Churg, A, Chirieac, LR, Burczuk, A, Dacic, S, Hammar, S, et al. Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.Google Scholar

Travis, LB, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.Google Scholar

Oury, TD, Sporn, TA, Roggli, VL. Pathology of asbestos-associated diseases. New York, NY: Springer, 2014.CrossRef Google Scholar

Makarawate, P, Chaosuwannakit, N, Chindaprasirt, J, Ungarreevittaya, P, Chaiwiriyakul, S, Wirasorn, K, et al. Malignant mesothelioma of the pericardium: a report of two different presentations. Case Rep Oncol Med. 2013;2013:356901.Google Scholar

Churg, A, Cagle, PT, Roggli, V. Tumors of the serosal membranes. Washington, DC: American Registry of Pathology, 2006.CrossRef Google Scholar

Brcic, L, Jakopovic, M, Brcic, I, Klaric, V, Milosevic, M, Sepac, A, et al. Reproducibility of histological subtyping of malignant pleural mesothelioma. Virchows Arch. 2014;465:679–85.Google Scholar

Mogi, A, Nabeshima, K, Hamasaki, M, Uesugi, N, Tamura, K, Iwasaki, A, et al. Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis. Pathol Int. 2009;59:874–79.Google Scholar

Mark, EJ, Shin, DH. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch A Pathol Anat Histopathol. 1993;422:445–51.CrossRef Google Scholar PubMed

Weissferdt, A, Kalhor, N, Suster, S. Malignant mesothelioma with prominent adenomatoid features: a clinicopathologic and immunohistochemical study of 10 cases. Ann Diagn Pathol. 2011;15:25–29.CrossRef Google Scholar PubMed

Ordonez, NG, Myhre, M, Mackay, B. Clear cell mesothelioma. Ultrastruct Pathol. 1996;20:331–36.CrossRef Google Scholar PubMed

Ordonez, NG, Mackay, B. Glycogen-rich mesothelioma. Ultrastruct Pathol. 1999;23:401–06.CrossRef Google Scholar PubMed

Ordonez, NG. Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases. Hum Pathol. 2005;36:465–73.CrossRef Google Scholar PubMed

Ustun, H, Astarci, HM, Sungu, N, Ozdemir, A, Ekinci, C. Primary malignant deciduoid peritoneal mesothelioma: a report of the cytohistological and immunohistochemical appearances. Diagn Cytopathol. 2011;39:402–08.CrossRef Google Scholar PubMed

Tsai, LY, Yang, YL, Lu, MY, Lin, DT, Huang, HY, Lin, KH. Deciduoid mesothelioma of the pleura in an adolescent boy. Pediatr Hematol Oncol. 2010;27:132–37.CrossRef Google Scholar

Talerman, A. Deciduoid or pseudodecidual mesothelioma. Am J Surg Pathol. 2000;24:1179.CrossRef Google Scholar PubMed

Shia, J, Erlandson, RA, Klimstra, DS. Deciduoid mesothelioma: a report of 5 cases and literature review. Ultrastruct Pathol. 2002;26:355–63.CrossRef Google Scholar PubMed

Serio, G, Scattone, A, Pennella, A, Giardina, C, Musti, M, Valente, T, et al. Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival. Histopathology. 2002;40:348–52.CrossRef Google Scholar PubMed

Santos, C, Gamboa, F, Fradinho, F, Pego, A, Carvalho, L, Bernardo, J. Deciduoid pleural mesothelioma–a rare entity in a young woman. Rev Port Pneumol. 2012;18:294–98.Google Scholar PubMed

Puttagunta, L, Vriend, RA, Nguyen, GK. Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change. Am J Surg Pathol. 2000;24:1440–43.Google Scholar

Orosz, Z, Nagy, P, Szentirmay, Z, Zalatnai, A, Hauser, P. Epithelial mesothelioma with deciduoid features. Virchows Arch. 1999;434:263–66.CrossRef Google Scholar PubMed

Ordonez, NG. Deciduoid mesothelioma: report of 21 cases with review of the literature. Mod Pathol. 2012;25:1481–95.CrossRef Google Scholar PubMed

Nascimento, AG, Keeney, GL, Fletcher, CD. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol. 1994;18:439–45.Google Scholar

Ordonez, NG. Epithelial mesothelioma with deciduoid features: report of four cases. Am J Surg Pathol. 2000;24:816–23.CrossRef Google Scholar PubMed

Gloeckner-Hofmann, K, Zhu, XZ, Bartels, H, Feller, AC, Merz, H. Deciduoid pleural mesothelioma affecting a young female without prior asbestos exposure. Respiration. 2000;67:456–58.Google Scholar

Desai, S, Kane, S, Bharde, S, Kulkarni, JN, Soman, CS. Malignant peritoneal mesothelioma deciduoid or anaplastic variant? A point to ponder. Indian J Pathol Microbiol. 2000;43:479–83.Google Scholar

Okonkwo, A, Musunuri, S, Diaz, L., Bedrossian, C, Stryker, S, Rao, S. Deciduoid mesothelioma: a rare, distinct entity with unusual features. Ann Diagn Pathol. 2001;5:168–71.CrossRef Google Scholar PubMed

Monaghan, H, Al-Nafussi, A. Deciduoid pleural mesothelioma. Histopathology. 2001;39:104–06.CrossRef Google Scholar PubMed

Henley, JD, Loehrer, PJ., Ulbright, TM. Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass. Am J Surg Pathol. 2001;25:547–48.CrossRef Google Scholar PubMed

Gillespie, FR, van der Walt, JD, Derias, N, Kenney, A. Deciduoid peritoneal mesothelioma. A report of the cytological appearances. Cytopathology. 2001;12:57–61.CrossRef Google Scholar PubMed

Desai, S, Kane, S, Bharde, S, Kulkarni, JN, Soman, CS. Malignant peritoneal mesothelioma deciduoid or anaplastic variant? Point to ponder. Indian J Pathol Microbiol. 2001;44:159–62.Google Scholar PubMed

Cook, HC. Small cell mesothelioma. Histopathology. 1993;22:294–95.Google Scholar PubMed

Tsao, AS, Heymach, J. Mesothelioma and small cell lung cancer. J Thorac Oncol. 2011;6:S1825–26.CrossRef Google Scholar PubMed

Takeda, T, Saitoh, M, Fukita, S, Takeda, S. Small cell carcinoma presenting with massive pleural spread mimicking malignant pleural mesothelioma. Intern Med. 2014;53:613–16.CrossRef Google Scholar PubMed

Allen, TC. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Arch Pathol Lab Med. 2005;129:1415–20.Google Scholar

Cook, DS, Attanoos, RL, Jalloh, SS, Gibbs, AR. ‘Mucin-positive’ epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall. Histopathology. 2000;37:33–36.Google Scholar

Ohnuma-Koyama, A, Yoshida, T, Takahashi, N, Akema, S, Takeuchi-Kashimoto, Y, Kuwahara, M, et al. Malignant peritoneal mesothelioma with a sarcomatoid growth pattern and signet-ring-like structure in a female f344 rat. J Toxicol Pathol. 2013;26:197–201.CrossRef Google Scholar

Ordonez, NG. Mesothelioma with signet-ring cell features: report of 23 cases. Mod Pathol. 2013;26:370–84.CrossRef Google Scholar PubMed

Rekhi, B, Pathuthara, S, Ajit, D, Kane, SV. “Signet-ring” cells – a caveat in the diagnosis of a diffuse peritoneal mesothelioma occurring in a lady presenting with recurrent ascites: an unusual case report. Diagn Cytopathol. 2010;38:435–39.CrossRef Google Scholar

Matsukuma, S, Aida, S, Hata, Y, Sugiura, Y, Tamai, S. Localized malignant peritoneal mesothelioma containing rhabdoid cells. Pathol Int. 1996;46:389–91.CrossRef Google Scholar PubMed

Ordonez, NG. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases. Mod Pathol. 2006;19:373–83.CrossRef Google Scholar PubMed

Ordonez, NG. Pleomorphic mesothelioma: report of 10 cases. Mod Pathol. 2012;25:1011–22.CrossRef Google Scholar PubMed

Kadota, K, Suzuki, K, Sima, CS, Rusch, VW, Adusumilli, PS, Travis, WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol. 2011;6:896–904.CrossRef Google Scholar PubMed

Husain, AN, Colby, TV, Ordonez, NG, Krausz, T, Borczuk, A, Cagle, PT, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009;133:1317–31.CrossRef Google Scholar PubMed

Marchevsky, AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med. 2008;132:397–401.CrossRef Google Scholar

Marchevsky, AM, Wick, MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol. 2007;15:140–44.Google Scholar

Yaziji, H, Battifora, H, Barry, TS, Hwang, HC, Bacchi, CE, McIntosh, MW, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006;19:514–23.Google Scholar

Battifora, H, Kopinski, MI. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985;55:1679–85.3.0.CO;2-C>CrossRef Google Scholar PubMed

Ordonez, NG. Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update. Hum Pathol. 2013;44:1–19.CrossRef Google Scholar PubMed

Jo, VY, Cibas, ES, Pinkus, GS. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology. Cancer Cytopathol. 2014;122:299–306.CrossRef Google Scholar PubMed

Ordonez, NG. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma. Mod Pathol. 2013;26:1132–43.Google Scholar

Ordonez, NG. Value of claudin-4 immunostaining in the diagnosis of mesothelioma. Am J Clin Pathol. 2013;139:611–19.CrossRef Google Scholar PubMed

Ohta, Y, Sasaki, Y, Saito, M, Kushima, M, Takimoto, M, Shiokawa, A, et al. Claudin-4 as a marker for distinguishing malignant mesothelioma from lung carcinoma and serous adenocarcinoma. Int J Surg Pathol. 2013;21:493–501.CrossRef Google Scholar PubMed

Facchetti, F, Lonardi, S, Gentili, F, Bercich, L, Falchetti, M, Tardanico, R, et al. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch. 2007;451:669–80.Google Scholar

Facchetti, F, Gentili, F, Lonardi, S, Bercich, L, Santin, A. Claudin-4 in mesothelioma diagnosis. Histopathology. 2007;51:261–63.CrossRef Google Scholar PubMed

Soini, Y, Kinnula, V, Kahlos, K, Paakko, P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006;59:250–54.CrossRef Google Scholar PubMed

Kimura, T, Doi, Y, Nakashima, T, Imano, N, Katsuta, T, Takahashi, S, et al. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy. J Radiat Res. 2015;56:315–24.CrossRef Google Scholar PubMed

Tsukamoto, Y, Hao, H, Kajimoto, N, Katayama, A, Suzuki, C, Terada, T, et al. Sarcomatoid pleural mesothelioma with osteosarcomatous, chondrosarcomatous and rhabdomyoblastic elements: an extremely rare autopsy case. Pathol Int. 2015;65:51–53.CrossRef Google Scholar PubMed

Liu, S, Staats, P, Lee, M, Alexander, HR, Burke, AP. Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients. Pathology. 2014;46:604–09.Google Scholar

Lee, M, Alexander, HR, Burke, A. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy. Pathology. 2013;45:464–73.CrossRef Google Scholar PubMed

Henderson, DW, Reid, G, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. J Clin Pathol. 2013;66:854–61.CrossRef Google Scholar PubMed

Nakamura, M, Kobashikawa, K, Uchima, N, Hirata, T. Sarcomatoid peritoneal malignant mesothelioma. Intern Med. 2011;50:2045.CrossRef Google Scholar PubMed

Klebe, S, Brownlee, NA, Mahar, A, Burchette, JL, Sporn, TA, Vollmer, RT, et al. Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. Mod Pathol. 2010;23:470–79.CrossRef Google Scholar PubMed

Salgado, RA, Corthouts, R, Parizel, PM, Germonpre, P, Carp, L, Van Schil, P, et al. Malignant pleural mesothelioma with heterologous osteoblastic elements: computed tomography, magnetic resonance, and positron emission tomography imaging characteristics of a rare tumor. J Comput Assist Tomogr. 2005;29:653–56.CrossRef Google Scholar PubMed

Chave, G, Chalabreysse, L, Picaud, G, Blineau, N, Loire, R, Thivolet, F, et al. Malignant pleural mesothelioma with osteoblastic heterologous elements: CT and MR imaging findings. AJR Am J Roentgenol. 2002;178:949–51.Google Scholar

Badak, B, Turk, O, Ates, E, Arik, D. Desmoplastic malignant mesothelioma of the peritoneum. Oxf Med Case Reports. 2014;2014:49–51.Google Scholar

Horiuchi, T, Ogata, S, Tominaga, S, Hiroi, S, Kawahara, K, Hebisawa, A, et al. Immunohistochemistry of cytokeratins 7, 8, 17, 18, and 19, and GLUT-1 aids differentiation of desmoplastic malignant mesothelioma from fibrous pleuritis. Histol Histopathol. 2013;28:663–70.Google Scholar

Baccioglu, A, Kaba, E, Ozmen, SA, Demirci, M. Desmoplastic malignant mesothelioma. J Bronchology Interv Pulmonol. 2013;20:155–58.CrossRef Google Scholar PubMed

Takamaru, H, Arimura, Y, Shinomura, Y. Desmoplastic malignant mesothelioma originating from the peritoneum. Med Oncol. 2012;29:3155–56.Google Scholar

Ishikawa, R, Kikuchi, E, Jin, M, Fujita, M, Itoh, T, Sawa, H, et al. Desmoplastic malignant mesothelioma of the pleura: autopsy reveals asbestos exposure. Pathol Int. 2003;53:401–06.CrossRef Google Scholar PubMed

Hirano, H, Maeda, H, Sawabata, N, Okumura, Y, Takeda, S, Maekura, R, et al. Desmoplastic malignant mesothelioma: two cases and a literature review. Med Electron Microsc. 2003;36:173–78.Google Scholar

Colby, TV. The diagnosis of desmoplastic malignant mesothelioma. Am J Clin Pathol. 1998;110:135–36.CrossRef Google Scholar PubMed

Thomas, JS, Burnett, RA. Desmoplastic mesothelioma. Thorax. 1988;43:584.Google Scholar

Cantin, R, Al-Jabi, M, McCaughey, WT. Desmoplastic diffuse mesothelioma. Am J Surg Pathol. 1982;6:215–22.Google Scholar

Yamamoto, J, Ueta, K, Takenaka, M, Takahashi, M, Nishizawa, S. Sarcomatoid malignant mesothelioma presenting with intramedullary spinal cord metastasis: a case report and literature review. Global Spine J. 2014;4:115–20.Google Scholar

Goldova, B, Dundr, P, Zikan, M, Tomancova, V. Myxoid variant of peritoneal epithelioid malignant mesothelioma. A case report. Cesk Patol. 2014;50:149–51.Google Scholar PubMed

Yang, GZ, Li, J, Ding, HY. Localized malignant myxoid anaplastic mesothelioma of the pericardium. J Clin Med Res. 2009;1:115–18.Google Scholar PubMed

Minato, H, Kurose, N, Fukushima, M, Nojima, T, Usuda, K, Sagawa, M, et al. Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol. 2014;141:85–93.CrossRef Google Scholar PubMed

Hyun, TS, Barnes, M, Tabatabai, ZL. The diagnostic utility of D2–40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Acta Cytol. 2012;56:527–32.CrossRef Google Scholar PubMed

Hasteh, F, Lin, GY, Weidner, N, Michael, CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:90–96.CrossRef Google Scholar PubMed

Geyer, SJ. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:225; author reply 225.CrossRef Google Scholar PubMed

Takeshima, Y, Amatya, VJ, Kushitani, K, Kaneko, M, Inai, K. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Histopathology. 2009;54:667–76.CrossRef Google Scholar PubMed

Salman, WD, Eyden, B, Shelton, D, Howat, A, Al-Dawoud, A, Twaij, Z. An EMA negative, desmin positive malignant mesothelioma: limitations of immunohistochemistry? J Clin Pathol. 2009;62:651–52.Google Scholar

Comin, CE, Dini, S, Novelli, L, Santi, R, Asirelli, G, Messerini, L. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type. Am J Surg Pathol. 2006;30:463–69.CrossRef Google Scholar PubMed

Comin, CE, Saieva, C, Messerini, L. h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol. 2007;31:1139–48.CrossRef Google Scholar PubMed

Shi, M, Fraire, AE, Chu, P, Cornejo, K, Woda, BA, Dresser, K, et al. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation. Am J Surg Pathol. 2011;35:878–82.CrossRef Google Scholar PubMed

Laury, AR, Hornick, JL, Perets, R, Krane, JF, Corson, J, Drapkin, R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34:627–35.CrossRef Google Scholar PubMed

Butnor, KJ, Sporn, TA, Ordonez, NG, Association of Directors of Anatomic and Surgical Pathology (ADASP). Recommendations for the reporting of pleural mesothelioma. Hum Pathol. 2007;38:1587–89.CrossRef Google Scholar PubMed

Davidson, B. Prognostic factors in malignant pleural mesothelioma. Hum Pathol. 2015;46:789–804.CrossRef Google Scholar PubMed

Scherpereel, A, Astoul, P, Baas, P, Berghmans, T, Clayson, H, de Vuyst, P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479–95.CrossRef Google Scholar PubMed

Chirieac, LR, Corson, JM. Pathologic evaluation of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21:121–24.Google Scholar

Kadota, K, Suzuki, K, Colovos, C, Sima, CS, Rusch, VW, Travis, WD, et al. A nuclear grading system is a strong predictor of survival in epithelioid diffuse malignant pleural mesothelioma. Mod Pathol. 2012;25:260–71.CrossRef Google Scholar

Yang, GC. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain. Cancer. 2003;99:17–22.Google Scholar

Zu, Y, Sidhu, GS, Wieczorek, R, Cassai, ND. Ultrastructurally “invasive” microvilli in an aggressively metastasizing biphasic malignant mesothelioma. Ultrastruct Pathol. 2002;26:403–09.Google Scholar

Coleman, M, Henderson, DW, Mukherjee, TM. The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu. 1989;24(Pt 1):303–53.Google Scholar PubMed

Oczypok, EA, Oury, TD. Electron microscopy remains the gold standard for the diagnosis of epithelial malignant mesothelioma: a case study. Ultrastruct Pathol. 2015;39:153–58.CrossRef Google Scholar PubMed

Suzuki, Y. Pathology of human malignant mesothelioma – preliminary analysis of 1,517 mesothelioma cases. Ind Health. 2001;39:183–85.CrossRef Google Scholar

Suzuki, Y. Pathology of human malignant mesothelioma. Semin Oncol. 1981;8:268–82.Google Scholar PubMed

Suzuki, Y, Kannerstein, M. Ultrastructure of human malignant diffuse mesothelioma. Am J Pathol. 1976;85:241–62.Google Scholar PubMed

Burns, TR, Greenberg, SD, Mace, ML, Johnson, EH. Ultrastructural diagnosis of epithelial malignant mesothelioma. Cancer. 1985;56:2036–40.3.0.CO;2-2>CrossRef Google Scholar PubMed

Guo, G, Chmielecki, J, Goparaju, C, Heguy, A, Dolgalev, I, Carbone, M, et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 2015;75:264–69.Google Scholar PubMed

Sekido, Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34:1413–19.CrossRef Google Scholar PubMed

Chung, CT, Santos, Gda C, Hwang, DM, Ludkovski, O, Pintilie, M, Squire, JA, et al. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol. 2010;63:630–34.CrossRef Google Scholar PubMed

Farzin, M, Toon, CW, Clarkson, A, Sioson, L, Watson, N, Andrici, J, et al. Loss of expression of BAP1 predicts longer survival in mesothelioma. Pathology. 2015;47:302–07.CrossRef Google Scholar PubMed

Alakus, H, Yost, SE, Woo, B, French, R, Lin, GY, Jepsen, K, et al. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma. J Transl Med. 2015;13:122.Google Scholar

Nasu, M, Emi, M, Pastorino, S, Tanji, M, Powers, A, Luk, H, et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10:565–76.CrossRef Google Scholar PubMed

Arzt, L, Quehenberger, F, Halbwedl, I, Mairinger, T, Popper, HH. BAP1 protein is a progression factor in malignant pleural mesothelioma. Pathol Oncol Res. 2014;20:145–51.CrossRef Google Scholar PubMed

de Klerk, N, Alfonso, H, Olsen, N, Reid, A, Sleith, J, Palmer, L, et al. Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia. Int J Cancer. 2013;132:1423–28.CrossRef Google Scholar PubMed

Bianchi, C, Bianchi, T. Pleural mesothelioma in a couple of brothers. Indian J Occup Environ Med. 2013;17:122–23.CrossRef Google Scholar

Bianchi, C, Brollo, A, Ramani, L, Bianchi, T, Giarelli, L. Familial mesothelioma of the pleura – a report of 40 cases. Ind Health. 2004;42:235–39.CrossRef Google Scholar PubMed

Ascoli, V, Mecucci, C, Knuutila, S. Genetic susceptibility and familial malignant mesothelioma. Lancet. 2001;357:1804.Google Scholar

Heineman, EF, Bernstein, L, Stark, AD, Spirtas, R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer. 1996;77:549–54.Google Scholar

Bianchi, C, Brollo, A, Zuch, C. Asbestos-related familial mesothelioma. Eur J Cancer Prev. 1993;2:247–50.Google Scholar

Hammar, SP, Bockus, D, Remington, F, Freidman, S, LaZerte, G. Familial mesothelioma: a report of two families. Hum Pathol. 1989;20:107–12.CrossRef Google Scholar PubMed

Lynch, HT, Katz, D, Markvicka, SE. Familial mesothelioma: review and family study. Cancer Genet Cytogenet. 1985;15:25–35.CrossRef Google Scholar PubMed

Li, FP, Lokich, J, Lapey, J, Neptune, WB, Wilkins, EW. Familial mesothelioma after intense asbestos exposure at home. JAMA. 1978;240:467.CrossRef Google Scholar PubMed

Orenstein, MR, Schenker, MB. Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med. 2000;6:371–77.CrossRef Google Scholar PubMed

Dawson, A, Gibbs, A, Browne, K, Pooley, F, Griffiths, M. Familial mesothelioma. Details of 17 cases with histopathologic findings and mineral analysis. Cancer. 1992;70:1183–87.3.0.CO;2-O>CrossRef Google Scholar PubMed

Li, FP, Dreyfus, MG, Antman, KH. Asbestos-contaminated nappies and familial mesothelioma. Lancet. 1989;1:909–10.Google Scholar PubMed

Abratt, RP, Vorobiof, DA, White, N. Asbestos and mesothelioma in South Africa. Lung Cancer. 2004;45(Suppl 1):S3–6.Google Scholar

Haliloglu, M, Hoffer, FA, Fletcher, BD. Malignant peritoneal mesothelioma in two pediatric patients: MR imaging findings. Pediatr Radiol. 2000;30:251–55.CrossRef Google Scholar PubMed

Goyal, M, Swanson, KF, Konez, O, Patel, D, Vyas, PK. Malignant pleural mesothelioma in a 13-year-old girl. Pediatr Radiol. 2000;30:776–78.CrossRef Google Scholar PubMed

Niggli, FK, Gray, TJ, Raafat, F, Stevens, MC. Spectrum of peritoneal mesothelioma in childhood: clinical and histopathologic features, including DNA cytometry. Pediatr Hematol Oncol. 1994;11:399–408.CrossRef Google Scholar PubMed

Kelsey, A. Mesothelioma in childhood. Pediatr Hematol Oncol. 1994;11:461–62.Google Scholar

Antman, KH, Ruxer, RL., Aisner, J, Vawter, G. Mesothelioma following Wilms’ tumor in childhood. Cancer. 1984;54:367–69.Google Scholar

Brenner, J, Sordillo, PP, Magill, GB. Malignant mesothelioma in children: report of seven cases and review of the literature. Med Pediatr Oncol. 1981;9:367–73.CrossRef Google Scholar PubMed

Kumar, R, Chitkara, NL. Peritoneal malignant mesothelioma in children. Indian J Cancer. 1966;3:190–97.Google Scholar

Arora, SK, Srinivasan, R, Nijhawan, R, Bansal, D, Menon, P. Malignant biphasic peritoneal mesothelioma in a child: fine-needle aspiration cytology, histopathology, and immunohistochemical features along with review of literature. Diagn Cytopathol. 2012;40:1112–15.Google Scholar

Paterson, A, Grundy, R, de Goyet, Jde V, Raafat, F, Beath, S, McCarthy, A. Congenital malignant peritoneal mesothelioma. Pediatr Radiol. 2003;33:73–74.CrossRef Google Scholar PubMed

Nishioka, H, Furusho, K, Yasunaga, T, Tanaka, K, Yamanouchi, A, Yokota, T, et al. Congenital malignant mesothelioma. A case report and electron-microscopic study. Eur J Pediatr. 1988;147:428–30.CrossRef Google Scholar PubMed

Hountis, P, Chounti, M, Matthaios, D, Romanidis, K, Moraitis, S. Surgical treatment for malignant pleural mesothelioma: extrapleural pneumonectomy, pleurectomy/decortication or extended pleurectomy? J BUON. 2015;20:376–80.Google Scholar

Elbahaie, AM, Kamel, DE, Lawrence, J, Davidson, NG. Late cutaneous metastases to the face from malignant pleural mesothelioma: a case report and review of the literature. World J Surg Oncol. 2009;7:84.CrossRef Google Scholar

Wagner, D, Bourne, PA, Yang, Q, Goldman, BI, Lewis, JS., Xu, H. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes. Appl Immunohistochem Mol Morphol. 2008;16:301–07.Google Scholar

Muljono, A, Ng, T, McMaster, J, Dexter, M. Choroid plexus metastases from pleural sarcomatoid mesothelioma. Pathology. 2008;40:530–32.CrossRef Google Scholar PubMed

Lester, T, Xu, H. Malignant pleural mesothelioma with osseous metastases and pathologic fracture of femoral neck. Appl Immunohistochem Mol Morphol. 2008;16:507–09.CrossRef Google Scholar PubMed

Abdel, Rahman AR, Gaafar, RM, Baki, HA, El Hosieny, HM, Aboulkasem, F, Farahat, EG, et al. Prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma. Ann Thorac Surg. 2008;86:391–95.Google Scholar

Teh, AY, Ball, D, O'Day, J, Cassumbhoy, R. Bilateral choroidal metastases from mesothelioma. J Thorac Oncol. 2006;1:712–13.Google Scholar

Cimbaluk, D, Kasuganti, D, Kluskens, L, Reddy, V, Gattuso, P. Malignant biphasic pleural mesothelioma metastatic to the liver diagnosed by fine-needle aspiration. Diagn Cytopathol. 2006;34:33–36.CrossRef Google Scholar

Tho, LM, O'Rourke, NP. Unusual metastases from malignant pleural mesothelioma. Clin Oncol (R Coll Radiol). 2005;17:293.CrossRef Google Scholar PubMed

Patel, T, Bansal, R, Trivedi, P, Modi, L, Shah, MJ. Subcutaneous metastases of sarcomatoid mesothelioma with its differential diagnosis on fine needle aspiration – a case report. Indian J Pathol Microbiol. 2005;48:482–84.Google Scholar

Mah, E, Bittar, RG, Davis, GA. Cerebral metastases in malignant mesothelioma: case report and literature review. J Clin Neurosci. 2004;11:917–18.CrossRef Google Scholar PubMed

Lumb, PD, Suvarna, SK. Metastasis in pleural mesothelioma. Immunohistochemical markers for disseminated disease. Histopathology. 2004;44:345–52.Google Scholar

Ambroggi, M, Orlandi, E, Foroni, RP, Cavanna, L. Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review. World J Surg Oncol. 2014;12:129.CrossRef Google Scholar

Miller, AC, Miettinen, M, Schrump, DS, Hassan, R. Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review. Ann Am Thorac Soc. 2014;11:1075–81.CrossRef Google Scholar PubMed

Purek, L, Laroumagne, S, Dutau, H, Maldonado, F, Astoul, P. Miliary mesothelioma: a new clinical and radiological presentation in mesothelioma patients with prolonged survival after trimodality therapy. J Thorac Oncol. 2011;6:1753–56.CrossRef Google Scholar PubMed

Musk, AW. More cases of miliary mesothelioma. Chest. 1995;108:587.CrossRef Google Scholar PubMed

Huncharek, M. Miliary mesothelioma. Chest. 1994;106:605–06.CrossRef Google Scholar PubMed

Musk, AW, Dewar, J, Shilkin, KB, Whitaker, D. Miliary spread of malignant pleural mesothelioma without a clinically identifiable pleural tumour. Aust N Z J Med. 1991;21:460–62.CrossRef Google Scholar PubMed

Mazurek, JM, Syamlad, G, Wood, JM, Hendricks, SA, Weston, A. Malignant mesothelioma mortality – United States, 1999–2015. MMWR Mortal Wkly Rep. 2017;66(8):214–18.Google Scholar PubMed

Taioli, E, Wolf, AS, Camacho-Rivera, M, Flores, RM. Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg. 2014;98:1020–24.CrossRef Google Scholar PubMed

Richards, WG, Godleski, JJ, Yeap, BY, Corson, JM, Chirieac, LR, Zellos, L, et al. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer. 2010;116:1510–17.Google Scholar PubMed

Miura, JT, Johnston, FM, Gamblin, TC, Turaga, KK. Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol. 2014;21:3947–53.Google Scholar

Magge, D, Zenati, MS, Austin, F, Mavanur, A, Sathaiah, M, Ramalingam, L, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159–65.CrossRef Google Scholar PubMed

Shih, CA, Ho, SP, Tsy, FW, Lai, KH, Hsu, PI. Diffuse malignant peritoneal mesothelioma. Kaohsiung J Med Sci. 2013;29:642–45.Google Scholar

Chua, TC, Chong, CH, Morris, DL. Peritoneal mesothelioma: current status and future directions. Surg Oncol Clin N Am. 2012;21:635–43.CrossRef Google Scholar PubMed

Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D, et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006;17:1615–19.Google Scholar

Andrici, J, Jung, J, Sheen, A, D'Urso, L, Sioson, L, Pickett, J, et al. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma. Hum Pathol. 2016;51:9–15.CrossRef Google Scholar PubMed

Judge, S, Thomas, P, Govindarajan, V, Sharma, P, Loggie, B. Malignant peritoneal mesothelioma: characterization of the inflammatory response in the tumor microenvironment. Ann Surg Oncol. 2016;23:1496–500.Google Scholar

Hubert, J, Thiboutot, E, Dube, P, Cloutier, AS, Drolet, P, Sideris, L. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: preliminary results and survival analysis. Surg Oncol. 2015;24:41–46.Google Scholar

Pillai, K, Pourgholami, MH, Chua, TC, Morris, DL. Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. J Cancer Res Clin Oncol. 2013;139:987–94.CrossRef Google Scholar PubMed

Hsu, LN, Sung, MT, Chiang, PH. Paratesticular malignant mesothelioma in a patient exposed to asbestos for more than 50 years. Kaohsiung J Med Sci. 2014;30:537–38.CrossRef Google Scholar

Manganiello, M, Cassalman, C, Dugan, J, Bennett, N. Scrotal mesothelioma. Can J Urol. 2014;21:7163–65.Google Scholar PubMed

Busto, Martin L, Portela, Pereira P, Sacristan, Lista F, Busto, Castanon L. Mesothelioma of the tunica vaginalis. Case report. Arch Esp Urol. 2013;66:384–88.Google Scholar

Shelton, D, Dalal, N. Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature. J Clin Pathol. 2012;65:958–59.CrossRef Google Scholar PubMed

Priester, P, Kopecky, J, Prosvicova, J, Petera, J, Zoul, Z, Slovacek, L. Cutaneous recurrence of malignant mesothelioma of the tunica vaginalis testis: a rare case report. Onkologie. 2012;35:46–48.Google Scholar

Belli, E, Landolfo, K. Primary pericardial mesothelioma: a rare cause of constrictive pericarditis. Asian Cardiovasc Thorac Ann. 2015;23:599–600.CrossRef Google Scholar PubMed

Gong, W, Ye, X, Shi, K, Zhao, Q. Primary malignant pericardial mesothelioma – a rare cause of superior vena cava thrombosis and constrictive pericarditis. J Thorac Dis. 2014;6:E272–75.Google Scholar PubMed

Oc, M, Oc, B, Dogan, R. Unexpected malignant pericardial mesothelioma presenting as pericardial constriction. Bratisl Lek Listy. 2012;113:620–21.Google Scholar PubMed

Feng, X, Zhao, L, Han, G, Khalil, M, Green, F, Ogilvie, T, et al. A case report of an extremely rare and aggressive tumor: primary malignant pericardial mesothelioma. Rare Tumors. 2012;4:e21.CrossRef Google Scholar PubMed

Kamiya, M, Eimoto, T. Malignant mesothelioma of the tunica vaginalis. Pathol Res Pract. 1990;186:680–84; discussion 685–86.CrossRef Google Scholar PubMed

Sardar, MR, Kuntz, C, Patel, T, Saeed, W, Gnall, E, Imaizumi, S, et al. Primary pericardial mesothelioma unique case and literature review. Tex Heart Inst J. 2012;39:261–64.Google Scholar

Choi, WS, Im, MS, Kang, JH, Kim, YG, Hwang, IC, Lee, JM, et al. Primary malignant pericardial mesothelioma presenting as acute pericarditis. J Cardiovasc Ultrasound. 2012;20:57–59.CrossRef Google Scholar PubMed

Tsuruya, K, Matsushima, M, Nakajima, T, Fujisawa, M, Shirakura, K, Igarashi, M, et al. Malignant peritoneal mesothelioma presenting umbilical hernia and Sister Mary Joseph's nodule. World J Gastrointest Endosc. 2013;5:407–11.Google Scholar

Chakravartty, S, Singh, JC, Jayamanne, H, Shah, V, Williams, GL, Stephenson, BM. Peritoneal mesothelioma masquerading as an inguinal hernia. Ann R Coll Surg Engl. 2012;94:e111–12.CrossRef Google Scholar PubMed

Chakravartty, S, Singh, JC, Jayamanne, H, Shah, V, Williams, GL, Stephenson, BM. Peritoneal mesothelioma masquerading as an inguinal hernia. Ann R Coll Surg Engl. 2011;93:e107–08.CrossRef Google Scholar PubMed

Stradella, A, Conde-Gallego, E, Escalera-Almendros, CA, Duran-Martinez, I. Malignant mesothelioma of tunica vaginalis. Actas Urol Esp. 2014;38:68–69.CrossRef Google Scholar PubMed

Lee, S, Illei, PB, Han, JS, Epstein, JI. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2014;38:54–59.CrossRef Google Scholar PubMed

Henderson, DW, Reid, G, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. J Clin Pathol. 2013;66:847–53.Google Scholar

Mangano, WE, Cagle, PT, Churg, A, Vollmer, RT, Roggli, VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol. 1998;110:191–99.CrossRef Google Scholar PubMed

Henderson, DW, Shilkin, KB, Whitaker, D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol. 1998;110:397–404.CrossRef Google Scholar PubMed

Cagle, PT, Churg, A. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies. Arch Pathol Lab Med. 2005;129:1421–27.CrossRef Google Scholar PubMed

Shen, J, Pinkus, GS, Deshpande, V, Cibas, ES. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol. 2009;131:516–23.CrossRef Google Scholar PubMed

Husain, AN, Mirza, MK, Gibbs, A, Hiroshima, K, Chi, Y, Boumendjel, R, et al. How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study. Lung Cancer. 2014;83:324–28.CrossRef Google Scholar PubMed

Kato, Y, Tsuta, K, Seki, K, Maeshima, AM, Watanabe, S, Suzuki, K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 2007;20:215–20.CrossRef Google Scholar PubMed

Hayes, JP, Wiggins, J, Ward, K, Muldowney, F, FitzGerald, MX. Familial cryptogenic fibrosing pleuritis with Fanconi's syndrome (renal tubular acidosis). A new syndrome. Chest. 1995;107:576–78.Google Scholar

Baris, YI, Sahin, AA, Ozesmi, M, Kerse, I, Ozen, E, Kolacan, B, et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax. 1978;33:181–92.CrossRef Google Scholar PubMed

Churg, A, Cagle, P, Colby, TV, Corson, JM, Gibbs, AR, Hammar, S, et al. The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas. Am J Surg Pathol. 2011;35:1823–29.Google Scholar

Lin, XM, Chi, C, Chen, J, Liu, Y, Li, P, Yang, Y. Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature. J Cardiothorac Surg. 2013;8:50.Google Scholar

Pritchard, SA, Howat, AJ, Edwards, JM. Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma. Histopathology. 2003;43:197–99.CrossRef Google Scholar PubMed

Johnson, JS, Edwards, JM. Malignant mesothelioma mimicking squamous carcinoma in a pleural fluid aspirate. Cytopathology. 2001;12:54–56.Google Scholar

Ordonez, NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215–21.CrossRef Google Scholar PubMed

Pelosi, G, Fabbri, A, Tamborini, E, Perrone, F, Testi, AM, Settanni, G, et al. Challenging lung carcinoma with coexistent DeltaNp63/p40 and thyroid transcription factor-1 labeling within the same individual tumor cells. J Thorac Oncol. 2015;10:1500–02.CrossRef Google Scholar PubMed

Agackiran, Y, Ozcan, A, Akyurek, N, Memis, L, Findik, G, Kaya, S. Desmoglein-3 and napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes. Appl Immunohistochem Mol Morphol. 2012;20:350–55.CrossRef Google Scholar

Kao, SC, Griggs, K, Lee, K, Armstrong, N, Clarke, S, Vardy, J, et al. Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology. 2011;43:313–17.Google Scholar

Kannerstein, M, Churg, J, McCaughey, WT, Hill, DP. Papillary tumors of the peritoneum in women: mesothelioma or papillary carcinoma. Am J Obstet Gynecol. 1977;127:306–14.CrossRef Google Scholar PubMed

Shukuya, T, Serizawa, M, Watanabe, M, Akamatsu, H, Abe, M, Imai, H, et al. Identification of actionable mutations in malignant pleural mesothelioma. Lung Cancer. 2014;86:35–40.CrossRef Google Scholar PubMed

Kawai, T, Hiroi, S, Nakanishi, K, Takagawa, K, Haba, R, Hayashi, K, et al. Lymphohistiocytoid mesothelioma of the pleura. Pathol Int. 2010;60:566–74.Google Scholar

Galateau-Sallé, F, Attanoos, R, Gibbs, AR, Burke, L, Astoul, P, Rolland, P, et al. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases. Am J Surg Pathol. 2007;31:711–16.Google Scholar

Yao, DX, Shia, J, Erlandson, RA, Klimstra, DS. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review. Ultrastruct Pathol. 2004;28:213–28.Google Scholar

Khalidi, HS, Medeiros, LJ, Battifora, H. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma. Am J Clin Pathol. 2000;113:649–54.Google Scholar PubMed

Henderson, DW, Attwood, HD, Constance, TJ, Shilkin, KB, Steele, RH. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol. 1988;12:367–84.CrossRef Google Scholar PubMed

Clevenger, J, Joseph, C, Dawlett, M, Guo, M, Gong, Y. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears. Cancer Cytopathol. 2014;122:779–85.Google Scholar

Granter, SR, Weilbaecher, KN, Quigley, C, Fisher, DE. Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl Immunohistochem Mol Morphol. 2002;10:47–51.CrossRef Google Scholar PubMed

Muramatsu, Y, Isobe, K, Sugino, K, Kinoshita, A, Wada, T, Sakamoto, S, et al. Malignant pleural mesothelioma mimicking the intrapulmonary growth pattern of epithelioid hemangioendothelioma. Pathol Int. 2014;64:358–60.CrossRef Google Scholar PubMed

Bahrami, A, Allen, TC, Cagle, PT. Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma. Pathol Int. 2008;58:730–34.CrossRef Google Scholar PubMed

Nind, NR, Attanoos, RL, Gibbs, AR. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma. Histopathology. 2003;42:150–55.Google Scholar

Attanoos, RL, Dallimore, NS, Gibbs, AR. Primary epithelioid haemangioendothelioma of the peritoneum: an unusual mimic of diffuse malignant mesothelioma. Histopathology. 1997;30:375–77.CrossRef Google Scholar PubMed

Lin, BT, Colby, T, Gown, AM, Hammar, SP, Mertens, RB, Churg, A, et al. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol. 1996;20:1431–39.CrossRef Google Scholar PubMed

Sullivan, HC, Edgar, MA, Cohen, C, Kovach, CK, HooKim, K, Reid, MD. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68:44–50.CrossRef Google Scholar PubMed

Fan, C, Liu, Y, Lin, X, Han, Y, He, A, Wang, E. Epithelioid angiosarcoma at chest wall which needs to be carefully distinguished from malignant mesothelioma: report of a rare case. Int J Clin Exp Pathol. 2014;7:9056–60.Google Scholar PubMed

Klabatsa, A, Nicholson, AG, Dulay, K, Rudd, RM, Sheaff, MT. Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components – a hitherto undescribed pattern of differentiation. Histopathology. 2012;60:1164–66.Google Scholar

Kao, YC, Chow, JM, Wang, KM, Fang, CL, Chu, JS, Chen, CL. Primary pleural angiosarcoma as a mimicker of mesothelioma: a case report. Diagn Pathol. 2011;6:130.CrossRef Google Scholar PubMed

Ordonez, NG. D2–40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol. 2005;36:372–80.CrossRef Google Scholar PubMed

Liu, B, Liu, L, Li, Y. Giant solitary fibrous tumor of the pleura: a case report. Thorac Cancer. 2015;6:368–71.CrossRef Google Scholar PubMed

Kamata, T, Sakurai, H, Nakagawa, K, Watanabe, SI, Tsuta, K, Asamura, H. Solitary fibrous tumor of the pleura: morphogenesis and progression. A report of 36 cases. Surg Today. 2016;46(3):335–40.CrossRef Google Scholar PubMed

Creytens, D, Libbrecht, L, Ferdinande, L. Nuclear expression of STAT6 in dedifferentiated liposarcomas with a solitary fibrous tumor-like morphology: a diagnostic pitfall. Appl Immunohistochem Mol Morphol. 2015;23:462–63.CrossRef Google Scholar PubMed

Benabdejlil, Y, Kouach, J, Babahabib, A, Elhassani, ME, Rharassi, I, Boudhas, A, et al. Intraperitoneal solitary fibrous tumor. Case Rep Obstet Gynecol. 2014;2014:906510.Google Scholar PubMed

Teo, A, Hemmings, C, Miller, R. Sarcomatoid localised mesothelioma mimicking intrapulmonary synovial sarcoma: a case report and review of the literature. Pathology. 2010;42:182–84.Google Scholar

Cappello, F, Barnes, L. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis. Pathology. 2001;33:142–48.Google Scholar

Weinbreck, N, Vignaud, JM, Begueret, H, Burke, L, Benhattar, J, Guillou, L, et al. SYT–SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura. Mod Pathol. 2007;20:617–21.Google Scholar

Somasundaram, S, Khajanchi, M, Vaja, T, Jajoo, B, Dey, AK. Benign multicystic peritoneal mesothelioma: a rare tumour of the abdomen. Case Rep Surg. 2015;2015:613148.Google Scholar PubMed

Marien, T, Zhou, M, Brucker, B. Benign multicystic mesothelioma masquerading as a urachal cyst. Can J Urol. 2014;21:7586–88.Google Scholar PubMed

Campbell, B, Mehanna, D, Stone, J. Benign multicystic peritoneal mesothelioma: a rare cause of intra-abdominal cystic disease. ANZ J Surg 2017;87(6):e15–16.CrossRef Google Scholar PubMed

Witek, TD, Marchese, JW, Farrell, TJ. A recurrence of benign multicystic peritoneal mesothelioma treated through laparoscopic excision: a case report and review of the literature. Surg Laparosc Endosc Percutan Tech. 2014;24:e70–73.Google Scholar

Momeni, M, Pereira, E, Grigoryan, G, Zakashansky, K. Multicystic benign cystic mesothelioma presenting as a pelvic mass. Case Rep Obstet Gynecol. 2014;2014:852583.Google Scholar PubMed

Mino, JS, Monteiro, R, Pigalarga, R, Varghese, S, Guisto, L, Rezac, C. Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature. BMJ Case Rep. 2014;2014:bcr2013200212.CrossRef Google Scholar

Wang, TB, Dai, WG, Liu, DW, Shi, HP, Dong, WG. Diagnosis and treatment of benign multicystic peritoneal mesothelioma. World J Gastroenterol. 2013;19:6689–92.CrossRef Google Scholar PubMed

Tamhankar, VA. Multicystic benign mesothelioma complicating pregnancy. Case Rep Obstet Gynecol. 2015;2015:687183.Google Scholar PubMed

Oks, M, He, T, Palkar, A, Esposito, MJ, Koenig, SJ. Benign multicystic mesothelioma causing bilateral pneumothoraces. Ann Am Thorac Soc. 2015;12:1106–09.CrossRef Google Scholar PubMed

Agarwal, S, Mullick, S, Gupta, K, Prasad, S. Pleural multicystic mesothelial proliferation: a mimicker of benign peritoneal mesothelioma. Indian J Pathol Microbiol. 2013;56:476–77.CrossRef Google Scholar PubMed

Singh, A, Chatterjee, P, Pai, MC, Chacko, RT. Multicystic peritoneal mesothelioma: not always a benign disease. Singapore Med J. 2013;54:e76–78.Google Scholar

McCaughey, WT, Colby, TV, Battifora, H, Churg, A, Corson, JM, Greenberg, SD, et al. Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel. Mod Pathol. 1991;4:342–53.Google Scholar

Galateau-Sallé, F, Vignaud, JM, Burke, L, Gibbs, A, Brambilla, E, Attanoos, R, et al. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol. 2004;28:534–40.CrossRef Google Scholar PubMed

McCaughey, WT, Al-Jabi, M, Kannerstein, M. A Canadian experience of the pathological diagnosis of diffuse mesothelioma. IARC Sci Publ. 1980;207–10.Google Scholar PubMed

Andrion, A, Magnani, C, Betta, PG, Donna, A, Mollo, F, Scelsi, M, et al. Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol. 1995;48:856–60.CrossRef Google Scholar PubMed

Skov, BG, Lauritzen, AF, Hirsch, FR, Skov, T, Nielsen, HW. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology. 1994;25:431–37.CrossRef Google Scholar PubMed

Val-Bernal, JF, Mayorga, M, Val, D, Garijo, MF. Well-differentiated papillary mesothelioma manifesting in a hernia sac. Pathol Res Pract. 2014;210:609–12.CrossRef Google Scholar

Nasit, JG, Dhruva, G. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology. Am J Clin Pathol. 2014;142:233–42.Google Scholar

Irwin, GW, Ervine, A, Kennedy, JA. Well-differentiated papillary mesothelioma: peritoneal implants are not always metastases in the presence of cancer. Scott Med J. 2014;59:e18–21.CrossRef Google Scholar

Erdogan, S, Acikalin, A, Zeren, H, Gonlusen, G, Zorludemir, S, Izol, V. Well-differentiated papillary mesothelioma of the tunica vaginalis: a case study and review of the literature. Korean J Pathol. 2014;48:225–28.CrossRef Google Scholar PubMed

Costanzo, L, Scarlata, S, Perrone, G, Rossi, L, Papa, A, Di Matteo, FM, et al. Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report. Clin Respir J. 2014;8:124–29.CrossRef Google Scholar PubMed

Washimi, K, Yokose, T, Amitani, Y, Nakamura, M, Osanai, S, Noda, H, et al. Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report. Pathol Int. 2013;63:220–25.CrossRef Google Scholar PubMed

Daya, D, McCaughey, WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer. 1990;65:292–96.3.0.CO;2-W>CrossRef Google Scholar

Burrig, KF, Pfitzer, P, Hort, W. Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol. 1990;417:443–47.CrossRef Google Scholar PubMed

Malpica, A, Sant'Ambrogio, S, Deavers, MT, Silva, EG. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012;36:117–27.Google Scholar

Hoekstra, AV, Riben, MW, Frumovitz, M, Liu, J, Ramirez, PT. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005;98:161–67.CrossRef Google Scholar PubMed

Churg, A, Allen, T, Borczuk, AC, Cagle, PT, Galateau-Sallé, F, Hwang, H, et al. Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol. 2014;38:990–98.CrossRef Google Scholar PubMed

Trpkov, K, Barr, R, Kulaga, A, Yilmaz, A. Mesothelioma of tunica vaginalis of “uncertain malignant potential” – an evolving concept: case report and review of the literature. Diagn Pathol. 2011;6:78.Google Scholar

Zardawi, SJ, Li, BT, Zauderer, MG, Wang, JW, Atmore, BB, Barnes, TA, et al. Localized malignant pleural mesothelioma with renal metastasis. Oxf Med Case Reports. 2015;2015:170–72.CrossRef Google Scholar PubMed

Giansanti, M, Bellezza, G, Guerriero, A, Pireddu, A, Sidoni, A. Localized intrasplenic mesothelioma: a case report. Int J Surg Pathol. 2013;22:451–55.Google Scholar PubMed

Gelvez-Zapata, SM, Gaffney, D, Scarci, M, Coonar, AS. What is the survival after surgery for localized malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg. 2013;16:533–37.CrossRef Google Scholar PubMed

Andrews, W, Paul, S, Narula, N, Altorki, NK. Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer. Interact Cardiovasc Thorac Surg. 2013;17:1061–62.Google Scholar

Nakano, T, Hamanaka, R, Oiwa, K, Nakazato, K, Masuda, R, Iwazaki, M. Localized malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2012;60:468–74.CrossRef Google Scholar PubMed

Morimoto, D, Fujimoto, N, Nishi, H, Asano, M, Fuchimoto, Y, Ono, K, et al. Malignant pleural mesothelioma localized in the thoracic wall. J Thorac Oncol. 2012;7:e21–22.CrossRef Google Scholar PubMed

Kim, Y, Lee, E, Jung, W, Kim, HK, Jung, SH, Hong, KD, et al. Localized malignant peritoneal mesothelioma arising in the mesentery of the ascending colon. Am Surg. 2012;78:E255–57.Google Scholar PubMed

Papalambros, A, Sigala, F, Vouza, EG, Hepp, W, Antonakis, P. Sister Mary Joseph's nodule as primary localized malignant mesothelioma. Report of a case. Zentralbl Chir. 2011;136:172–74.Google Scholar

Ouazzani, A, Rondelet, B, Sokolow, Y, Ruiz, Patino M, Remmelink, M, Cappello, M. Localized malignant lymphohistiocytoid pleural mesothelioma. Acta Chir Belg. 2011;111:38–43.Google Scholar

Hayashi, H, Notohara, K, Yoshioka, H, Matsuoka, T, Ikeda, H, Kagawa, K, et al. Localized malignant pleural mesothelioma showing a thoracic mass and metastasizing to the stomach. Intern Med. 2010;49:671–75.CrossRef Google Scholar PubMed

Tanzi, S, Tiseo, M, Internullo, E, Cacciani, G, Capra, R, Carbognani, P, et al. Localized malignant pleural mesothelioma: report of two cases. J Thorac Oncol. 2009;4:1038–40.CrossRef Google Scholar PubMed

Akamoto, S, Ono, Y, Ota, K, Suzaki, N, Sasaki, A, Matsuo, Y, et al. Localized malignant mesothelioma in the middle mediastinum: report of a case. Surg Today. 2008;38:635–38.Google Scholar

Takahashi, H, Harada, M, Maehara, S, Kato, H. Localized malignant mesothelioma of the pleura. Ann Thorac Cardiovasc Surg. 2007;13:262–66.Google Scholar PubMed

Allen, TC, Cagle, PT, Churg, AM, Colby, TV, Gibbs, AR, Hammar, SP, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866–73.Google Scholar

Robinson, LA, Reilly, RB. Localized pleural mesothelioma. The clinical spectrum. Chest. 1994;106:1611–15.CrossRef Google Scholar PubMed

You, Q, Zhao, J, Shi, G, Deng, J, Teng, X. Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child. Int J Clin Exp Pathol. 2014;7:2636–40.Google Scholar PubMed

Kuroda, K, Ishizawa, S, Kudo, T, Uotani, H, Hosokawa, A, Tanaka, T, et al. Localized malignant mesenteric mesothelioma causing small bowel obstruction. Pathol Int. 2008;58:239–43.CrossRef Google Scholar PubMed

Al-Qahtani, M, Morris, B, Dawood, S, Onerheim, R. Malignant mesothelioma of the tunica vaginalis. Can J Urol. 2007;14:3514–17.Google Scholar PubMed

Erdogan, E, Demirkazik, FB, Gulsun, M, Ariyurek, M, Emri, S, Sak, SD. Incidental localized (solitary) mediastinal malignant mesothelioma. Br J Radiol. 2005;78:858–61.CrossRef Google Scholar PubMed

Hirano, H, Takeda, S, Sawabata, Y, Okumura, Y, Maeda, H, Hanibuchi, M, et al. Localized pleural malignant mesothelioma. Pathol Int. 2003;53:616–21.Google Scholar

Book contents

11 - Pathology of Malignant Mesothelioma

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive